Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Measuring the effects of atomoxetine and methylphenidate on working memory in children and adolescents with ADHD

FY 2008-09

Summary
Working memory is the ability to hold and manipulate information in one's mind over a brief time period. Working memory is needed for many activities in everyday life and is also essential for academic success. Many individuals with attention-deficit/hyperactivity disorder (ADHD) have problems with working memory and with performance in school. Currently, the long-acting stimulant and nonstimulant medications Concerta methylphenidate (MPH) and atomoxetine (ATX) are widely used for treating behaviour in those with ADHD. As a result, it is important both clinically and theoretically to understand how these medications influence working memory in ADHD. Although the effects of these medications on working memory have not directly looked at, the limited evidence (based mainly on animal data and nonrandomized study designs) suggests that impaired working memory may be improved by both Concerta MPH and ATX. The objective of this study is to determine the effects of Concerta MPH and ATX for improving working memory deficits and associated functional impairment (e.g., school performance) in children and adolescents with ADHD. We will also be looking at how much medication is needed for the best response, and why some children with ADHD may respond better to one medication over the other. We will use computerized working memory measures, standardized curriculum based measures of academic achievement, and neuroimaging techniques in order to better understand how children with ADHD remember information and how medication impacts working memory. We predict that while many children will have better working memory and do better on school tests with both treatments, some children will do better with one medication over the other, because Concerta MPH and ATX work in slightly different ways in the brain. This project will contribute to our understanding of working memory and results will have significant implications for the treatment of children with ADHD.
Program
CIHR Fellowship
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
174280
Name
Bedard Anne-Claude V
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Fellowships - Post-PhD
Projecttitle
Measuring the effects of atomoxetine and methylphenidate on working memory in children and adolescents with ADHD
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Adhd; Adolescents; Atomoxetine; Children; Cognition; Fmri; Methylphenidate; Neuroimaging; Working Memory
Abstract
Working memory is the ability to hold and manipulate information in one's mind over a brief time period. Working memory is needed for many activities in everyday life and is also essential for academic success. Many individuals with attention-deficit/hyperactivity disorder (ADHD) have problems with working memory and with performance in school. Currently, the long-acting stimulant and nonstimulant medications Concerta methylphenidate (MPH) and atomoxetine (ATX) are widely used for treating behaviour in those with ADHD. As a result, it is important both clinically and theoretically to understand how these medications influence working memory in ADHD. Although the effects of these medications on working memory have not directly looked at, the limited evidence (based mainly on animal data and nonrandomized study designs) suggests that impaired working memory may be improved by both Concerta MPH and ATX. The objective of this study is to determine the effects of Concerta MPH and ATX for improving working memory deficits and associated functional impairment (e.g., school performance) in children and adolescents with ADHD. We will also be looking at how much medication is needed for the best response, and why some children with ADHD may respond better to one medication over the other. We will use computerized working memory measures, standardized curriculum based measures of academic achievement, and neuroimaging techniques in order to better understand how children with ADHD remember information and how medication impacts working memory. We predict that while many children will have better working memory and do better on school tests with both treatments, some children will do better with one medication over the other, because Concerta MPH and ATX work in slightly different ways in the brain. This project will contribute to our understanding of working memory and results will have significant implications for the treatment of children with ADHD.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bedard, Anne-Claude V
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~